assessment: * Assessment of force-velocity and power-velocity relationships in each leg during a cycling task
* Assessment of unilateral force-velocity and power-velocity relationships during a knee extension task
* Assessment of maximum force and explosive force in isometric (static) conditions of the knee extensors.
* Measurement of scores using questionnaires (IKDC-SKF).
Study summary
The goal of this clinical trial is to to determine the extent of the association between objective changes in the muscle function of the knee extensors (strength and power) and the function reported by the patient following ACL reconstruction surgery. The main questions it aims to answer is:
\- Pre- and post-operative (6 months) changes in maximum knee extensor strength following ACL reconstruction, correlated with the IKDC-SKF score.
Eligibility
Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria:
* Patients requiring isolated or complex ACL reconstruction (combined with a meniscal injury)
* Patients who are physically active (Tegner score ≥ 4) and wish to resume such activity.
* Patients with no history of surgery on the ipsilateral knee (i.e., native knee).
* Patients able to comply with the study procedures
* Patients who have given their free and informed written consent, having been informed of the purpose of the study, its procedure and its risks.
* Be affiliated to a social security scheme.
Exclusion Criteria:
* Patient with comprehension difficulties
* Recurrent rupture of the ipsilateral ACL
* Multi-ligament injuries (i.e., injury to the medial collateral ligament, lateral collateral ligament or posterior cruciate ligament)
Primary outcome measure(s)
Correlation of maximum knee extension strength to IKDC-SKF scores — 6 month Relationship (r coefficient) between 0-6 month delta of maximum knee extension strength measurements and International Knee Documentation Commitee-SKF scores (100: no limitation)
Trial sites (1)
Facility
City
Region
Status
Médipôle de Savoie
Challes-les-Eaux
France
Recruiting
More Centre Hospitalier Metropole Savoie trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
